Image

Global Genotyping Market – Industry Trends and Forecast to 2031

Healthcare

Image

Global Genotyping Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Jul 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Genotyping Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 17.29 Billion
Diagram Market Size (Forecast Year) USD 51.41 Billion
Diagram CAGR %

Major Markets Players

  • Illumina
  • Inc. (U.S.)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Thermo Fisher Scientific
  • Inc. (U.S.)

Global Genotyping Market, By Product (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services),  Technology (Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others Technologies), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other) – Industry Trends and Forecast to 2031.

 Genotyping Market

Genotyping Market Analysis and Size

The genotyping market has experienced strong growth, driven by advances in genomic research, personalized medicine, and agricultural biotechnology. Technologies like microarrays, next-generation sequencing (NGS), and polymerase chain reaction (PCR) have revolutionized genetic analysis, enabling rapid and precise identification of genetic variations across various applications. This advancement has fueled a significant increase in demand for pharmacogenomics, where treatments are customized based on individual genetic profiles, resulting in enhanced treatment efficacy and reduced side effects. For instance, in August 2022, Thermo Fisher Scientific launched the Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research-only assay designed to identify genetic variants of human immunodeficiency virus (HIV) that resist common antiretroviral drugs. This demonstrates how genomic technologies are applied to diagnose and manage diseases more effectively, further driving the adoption and growth of genotyping technologies in healthcare and research.

Global genotyping market size was valued at USD 17.29 billion in 2023 and is projected to reach USD 51.41 billion by 2031, with a CAGR of 14.59% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services),  Technology (Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others Technologies), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America

Market Players Covered

Illumina, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), Qiagen N.V. (Germany), Fluidigm Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Oxford Nanopore Technologies, Ltd. (U.K.), Pacific Biosciences of California, Inc. (U.S.)., Genewiz, Inc. (U.S.), Genomic Health, Inc. (U.S.), Eurofins Scientific SE (Germany), BGI Group (China), Danaher Corporation (U.S.), Luminex Corporation (U.S.)

Market Opportunities

  • Advancements in Data Analytics 
  • Rise in Direct-to-Consumer Genetic Testing

Market Definition

Genotyping refers to the process of determining the genetic makeup or genotype of an organism by analyzing its DNA sequence or specific genetic markers. This analytical technique enables researchers to identify genetic variations, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and other structural changes in the genome. Genotyping plays a crucial role in various fields of biology and medicine, including personalized medicine, pharmacogenomics, agricultural biotechnology, and evolutionary biology.                         

Genotyping Market Dynamics

Drivers     

  • Growing Applications in Agriculture   

Genotyping technologies offer precise genetic information that aids in selecting traits for desirable agricultural outcomes. In crop improvement, genotyping helps identify markers associated with traits like disease resistance, yield potential, and nutrient efficiency, enabling breeders to develop superior crop varieties. Similarly, in livestock breeding, genotyping assists in identifying desirable genetic traits for breeding programs aimed at enhancing meat quality, milk production, and disease resistance. Moreover, genotyping plays a crucial role in biodiversity conservation by facilitating genetic diversity assessments and aiding in the preservation of endangered species and wild populations. The increasing adoption of genotyping services in agriculture is significantly enhancing market growth through applications in crop improvement, livestock breeding, and biodiversity conservation.     

  • Advancements in Genomic Research     

NGS technologies, known for their high throughput and cost-effectiveness in sequencing large volumes of DNA, RNA, or whole genomes, have expanded the scope of genomic studies. They enable researchers to explore complex genetic variations associated with diseases, drug responses, and population genetics with genotyping and sequencing. Microarray technologies, on the other hand, allow for simultaneous analysis of thousands to millions of genetic markers, facilitating genome-wide association studies (GWAS) and gene expression profiling. These technological advancements not only accelerate genomic research but also support advancements in personalized medicine, agricultural biotechnology, and evolutionary biology, driving innovation and growth in the genotyping market globally.   

Opportunities       

  • Innovations in Data Analytics

Innovations in bioinformatics and data analytics solutions are revolutionizing genotyping by enhancing the capability to interpret genomic data accurately and efficiently. Bioinformatics tools and algorithms enable researchers to analyze vast amounts of genomic information, identify genetic variations, and correlate them with phenotypic traits or disease outcomes. Advanced data analytics techniques, such as machine learning and artificial intelligence, further improve the accuracy of genomic predictions and enhance the understanding of complex genetic interactions. These developments are crucial for translating genomic data into actionable insights for personalized medicine, drug discovery, and precision agriculture.     

  • Rise in Direct-to-Consumer Genetic Testing            

The rise in consumer interest in direct-to-consumer genetic testing services is creating new market avenues for genotyping. These services offer individuals access to genetic information related to ancestry, health risks, and lifestyle traits without the need for healthcare provider involvement. Consumers increasingly seek genetic testing for insights into their genetic predispositions to diseases, personalized nutrition plans, and ancestry tracing. The convenience and accessibility of direct-to-consumer genetic tests have democratized genetic information, empowering individuals to make informed decisions about their health and well-being. This trend is driving the expansion of the genotyping market beyond traditional healthcare settings into direct consumer markets, fostering innovation in genetic testing technologies and services.

Restraints/Challenges

  • High Cost of Instruments and Services     

Genotyping technologies require substantial investment in specialized equipment, such as sequencing platforms and microarray scanners, which can be prohibitively expensive for small research laboratories or healthcare facilities. Additionally, the cost of reagents and consumables for genomic analysis contributes to the overall expense of genotyping experiments. These financial considerations limit the accessibility of genotyping technologies in resource-constrained regions, hindering their widespread adoption and application in research and clinical diagnostics.     

  • Complexity of Data Analysis     

Genotyping platforms produce vast amounts of genetic information, including single nucleotide polymorphisms (SNPs), copy number variations (CNVs), and structural variants, which require sophisticated bioinformatics tools for processing and interpretation. Researchers face challenges in data storage, integration, quality control, and standardized analysis pipelines to derive meaningful insights from genomic datasets. The complexity of handling and interpreting large-scale genomic data generated from genotyping technologies presents significant challenges in data management and analysis.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In January 2024, Thermo Fisher Scientific introduced the AxiomTM PangenomiX Array*, its most extensive and ethnically diverse array yet. This new array provides comprehensive genetic coverage, specifically tailored for large-scale disease studies and pharmacogenomic research at a population level              
  • In May 2022, Neogen Corporation and Gencove, a prominent provider of low-pass whole genome sequencing and analysis software, introduced InfiniSEEK, an innovative and cost-efficient solution designed for comprehensive whole genome sequencing and targeted SNP analysis. By integrating Neogen's advanced genomic services with Gencove's cutting-edge sequencing technology and analytics software, this solution aims to enhance cattle breeding programs globally by providing valuable genomic insights

Genotyping Market Scope

The market is segmented on the basis of product, technology, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

Technology

Application

  • Pharmacogenomics
  • Diagnostics and Personalized Medicine
  • Animal Genetics
  • Agricultural Biotechnology
  • Others

End Users

  • Pharmaceutical and Biopharmaceutical Companies
  • Diagnostic and Research Laboratories
  • Academic Institutes
  • Other

Genotyping Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, product, technology, application, and end-user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to robust healthcare infrastructure, substantial presence of key market players, and increasing research initiatives.       

Asia-Pacific is expected to witness significant growth during the forecast period due to government efforts to boost awareness, expanding healthcare infrastructure, rising research endeavors, access to untapped markets, a large population base, and escalating demand for high-quality healthcare services across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Genotyping Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

  • Illumina, Inc. (U.S.)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Qiagen N.V. (Germany)
  • Fluidigm Corporation (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • Oxford Nanopore Technologies, Ltd. (U.K.)
  • Pacific Biosciences of California, Inc. (U.S.)
  • Genewiz, Inc. (U.S.)
  • Genomic Health, Inc. (U.S.)
  • Eurofins Scientific SE (Germany)
  • BGI Group (China)
  • Danaher Corporation (U.S.)
  • Luminex Corporation (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Genotyping Market Will be worth USD 51.41 billion by 2031
The Growth Rate of the Genotyping Market will be 14.59% by 2031
The major companies in the Genotyping Market are Illumina, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), Qiagen N.V. (Germany), Fluidigm Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Oxford Nanopore Technologies, Ltd. (U.K.), Pacific Biosciences of California, Inc. (U.S.)., Genewiz, Inc. (U.S.), Genomic Health, Inc. (U.S.), Eurofins Scientific SE (Germany), BGI Group (China), Danaher Corporation (U.S.), Luminex Corporation (U.S.), Etc.
The Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology are the market applications of the Genotyping Market.
The latest development in the Genotyping Market are Thermo Fisher Scientific introduced the AxiomTM PangenomiX Array and Neogen Corporation and Gencove, a prominent provider of low-pass whole genome sequencing and analysis software.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials